J Cancer Educ
Education, MedicalFellowships and ScholarshipsHematology
Dr. Liudmila N. Schafer, MD
NPI1114106515PAC ID6608944939
- Medicare services, 2023
- 245
- Part D claims, 2024
- 21
- Publications
- 3
- Clinical trials
- 6
- Hospital affiliations
- 5
- Practice address
- 110 Irving Street NW, Washington, DC 20010
- Practice phone
- Call (202) 877-7000
- Professional email
- Get professional email
- Personal email
- Get personal email
- Mobile number
- Get mobile number
Primary practice
Find Dr. Schafer's professional email, personal email and mobile number
Dmand AI checks each channel through healthcare-specific waterfall enrichment. See what is on file with a free account, with practice phones, licenses and affiliations.
Dr. Liudmila N. Schafer is a hematologist and oncologist in Washington, District of Columbia
Dr. Schafer practices at MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health.
Dr. Schafer's NPI, 1114106515, was assigned on November 1, 2007. Dr. Schafer holds Missouri license 2019047145.
NPI and contact details
- NPI
- 1114106515NPI Registry (opens in a new tab)
- Medicare PAC ID
- 6608944939
- NPI enumeration date
- November 1, 2007
- NPI status
- Active
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
- Practice phone
- (202) 877-7000
- Professional email
- Get email
- Personal email
- Get email
- Mobile number
- Get number
- Sex
- Female
- Estimated age
- 56
- Medical school graduation
- 1996
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; Dmand AI Affiliation Data; and Doctors and Clinicians National Downloadable File (CMS)
Dr. Liudmila N. Schafer practices at MedStar Washington Hospital Center in Washington, District of Columbia
Dr. Schafer's primary practice is MedStar Washington Hospital Center, at 110 Irving Street NW, Washington, DC 20010 in The District County. The practice phone is (202) 877-7000.
- MedStar Washington Hospital Center110 Irving Street NW, Washington, DC 20010 · The District CountyPhone(202) 877-7000
Source: Dmand AI Affiliation Data
Dr. Liudmila N. Schafer is affiliated with 8 sites of care and 5 medical groups
Dr. Schafer's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dr. Schafer is also affiliated with MedStar Georgetown University Hospital. The medical group on file is MedStar Medical Group. Dmand AI also links Dr. Schafer to 3 more hospitals, 4 medical groups and 3 group practices and clinics, each named with a free account.
MedStar Georgetown University HospitalMedStar Medical Group3 hospitalsNames with a free account4 medical groupsNames with a free account3 group practices and clinicsNames with a free account
See all 13 affiliations for Dr. SchaferSources: Dmand AI Affiliation Data; and Dmand AI Org Hierarchy Data
Dmand AI tracks the EHR system at Dr. Liudmila N. Schafer's practice
Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Schafer practices, 8 sites in all. Vendor and product names are available with a free account.
| Site | EHR vendor and product |
|---|---|
| MedStar Washington Hospital Center | Available with a free account |
| +7 more sites and 4 medical groups | Available with a free account |
Source: Dmand AI Technology Install Data
For health IT teams
See the EHR and IT leaders at every hospital where Dr. Schafer practices
Dmand AI maps EHR vendors, IT decision makers and buying committees across MedStar Health and 6.2K+ hospitals, with verified contacts in the same login.
Dr. Liudmila N. Schafer is one of 66 hematologists and oncologists in District of Columbia
Hematology and oncology is Dr. Schafer's primary specialty in the NPI Registry, under taxonomy code 207RH0003X. Dmand AI has Dr. Schafer's licenses on file in 4 states: Missouri, Arkansas, Kansas and Tennessee.
Specialties and state licenses
- Hematology and oncology, MissouriPrimary
- Medical oncology, Arkansas
- Kansas license
- Internal medicine, Tennessee
Hematologists and oncologists near Dr. Schafer
Counts of hematologists and oncologists with a Dmand AI profile, by place and practice. Each opens the list.
66hematologists and oncologists in District of Columbia66hematologists and oncologists in Washington12hematologists and oncologists at MedStar Washington Hospital Center
Sources: NPPES NPI Registry (CMS); Dmand AI Professional Profile Data; and Dmand AI Peer Benchmarks
Dr. Liudmila N. Schafer billed Medicare for 245 services in 2023
CMS data shows 245 Medicare services from Dr. Schafer across 3 procedure codes in 2023, all of them office visits. Medicare paid $21,842 for them.
Medicare services, 2023245
Paid by Medicare$21,842
Procedure codes3
Dr. Schafer's Medicare services by type, 2022 to 2023
- 2022
- 2023
- Office and hospital visits
- 2022: 2552023: 2454%
- Drugs given in the office
- 2022: 6,9312023: 0100%
- Lab and pathology
- 2022: 5732023: 0100%
- Tests and treatments
- 2022: 2102023: 0100%
- Surgery
- 2022: 1572023: 0100%
Where Dr. Schafer's Medicare services took place, 2023
- In an office22592%
- In a facility208%
Dr. Schafer compared with the District of Columbia median for hematologists and oncologists, 2023
- Dr. Schafer
- District of Columbia median
- Medicare services
- 245vs 39638% below
- Part D claims
- 13vs 11489% below
Medians across 62 hematologists and oncologists in District of Columbia with Dmand AI profiles that report each measure.
Dr. Schafer's most billed Medicare procedure codes, 2023
CMS publishes codes billed for 11 or more Medicare patients. Each label is the code family; CPT descriptions are licensed by the AMA.
Need commercial claims for Dr. Schafer?
Medicare shows one payer. Book a meeting to get commercial claims data for Dr. Schafer and other hematologists and oncologists in District of Columbia.
Sources: Medicare Physician & Other Practitioners - by Provider and Service (CMS), 2024 data; and Dmand AI Peer Benchmarks
Dr. Liudmila N. Schafer's patients have a median age of 75
Across all payers, Dmand AI patient panel data puts Dr. Schafer's median patient age at 75, with 57% women.
Dr. Schafer's patients across all payers
Dmand AI patient panel data covers Medicare, Medicaid and commercial patients.
Patient panel by age, all payers
Median age 75
Patient panel by sex, all payers
- Women57%
- Men42%
Source: Dmand AI Patient Panel Data
Dr. Liudmila N. Schafer wrote 21 Medicare Part D claims in 2024
In 2024, Dr. Schafer wrote 21 Medicare Part D claims. CMS names the drug for 13 of them, across 1 drug with 11 or more claims each, at $7,397 in total drug cost. In 2023, CMS named 130 claims across 7 drugs.
Part D claims, 202421
Drugs named by CMS1
Total drug cost$7,397
Dr. Schafer's most prescribed drugs by claims, 2024
CMS names a drug when it has 11 or more claims. Share is of the claims for drugs CMS names.
Part D claims for drugs CMS names, 2023 to 2024
- 2023
- 2024
- Claims for drugs CMS names
- 2023: 1302024: 1390%
Drugs named by CMS: 1 in 2024, 7 in 2023.
Sources: Medicare Part D Prescribers - by Provider and Drug (CMS), 2024 data, released May 6, 2026; and Medicare Part D Prescribers - by Provider (CMS), 2024 data
Dr. Liudmila N. Schafer offers telehealth to Medicare patients
Dr. Schafer accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Schafer as offering telehealth.
- Accepts Medicare assignment
- Yes
- Offers telehealth
- Yes
Source: Doctors and Clinicians National Downloadable File (CMS)
For MedTech and pharma teams
Find hematologists and oncologists like Dr. Schafer by procedure volume and prescribing
Filter 7.4M+ HCPs by Medicare procedures, Part D drugs and Open Payments history, then reach them with verified contacts in one login.
Dr. Liudmila N. Schafer has 3 publications on record
Dmand AI links 3 papers to Dr. Schafer. Dr. Schafer's most frequent co-authors are Matthew C. Aboudara, MD, Konstantinos Arnaoutakis, MD and John J. Borsa, MD.
Papers3
Dr. Schafer's most frequent co-authors
- Matthew C. Aboudara, MD1 shared paper
- Konstantinos Arnaoutakis, MD1 shared paper
- John J. Borsa, MD1 shared paper
Recent publications by Dr. Schafer
Arch Pathol Lab Med
CommunicationLaboratoriesPrecision Medicine
See who Dr. Schafer researches with
Physician Network Discovery turns co-authorship, shared hospitals and shared groups into a map of who Dr. Schafer works with, so you can find a warm path to the right hematologists and oncologists.
Sources: PubMed (National Library of Medicine); and Dmand AI Research Linkage
Dr. Liudmila N. Schafer has worked on 6 clinical trials
Dmand AI links Dr. Schafer to 6 clinical trials, 3 of them phase 3 studies. 4 are still active or recruiting. Conditions studied include Rectal Diseases, Cholangiocarcinoma and Non functioning pancreatic endocrine tumor. Alliance for Clinical Trials in Oncology sponsors the most, 2.
Clinical trials with Dr. Schafer by phase
- NonePhase 1: no trials
- 2Phase 2: 2 trials
- 1Phase 2/3: 1 trial
- 3Phase 3: 3 trials
- NonePhase 4: no trials
Conditions in Dr. Schafer's trials
- Rectal Diseases
- Cholangiocarcinoma
- Non functioning pancreatic endocrine tumor
- Rectal Neoplasms
- Squamous Cell Carcinoma of Head and Neck
Investigators on the most trials with Dr. Schafer
- Minaxi Jhawer, MBBS4 shared trials
- Namrata Vijayvergia, MD3 shared trials
- Steven Ades, MD2 shared trials
Recent clinical trials with Dr. Schafer
Phase 2 Single Arm Trial of Cisplatin, Nab-Paclitaxel, and Cetuximab (CACTUX) in Patients With Incurable Head and Neck Squamous Cell Carcinoma (HNSCC) (opens in a new tab)
Active, not recruitingPhase 2
Squamous Cell Carcinoma of Head and NeckCarcinoma, Squamous CellCetuximabCisplatinNab-paclitaxel
Duloxetine to Prevent Oxaliplatin-Induced Peripheral Neuropathy in Patients with Stage II-III Colorectal Cancer (opens in a new tab)
Active, not recruitingPhase 2/3
Rectal DiseasesColorectal NeoplasmsDuloxetineOxaliplatinDuloxetine Hydrochloride
Vitamin D3 with Chemotherapy and Bevacizumab in Treating Patients with Advanced or Metastatic Colorectal Cancer (opens in a new tab)
Active, not recruitingPhase 3
BevacizumabFluorouracilIrinotecan
Randomized Phase III Study of Focal Radiation Therapy for Unresectable, Localized Intrahepatic Cholangiocarcinoma (opens in a new tab)
TerminatedPhase 3
CholangiocarcinomaAdenocarcinomaImage Guided Radiation Therapy
Testing Cabozantinib in Patients With Advanced Pancreatic Neuroendocrine and Carcinoid Tumors (opens in a new tab)
Active, not recruitingPhase 3
Non functioning pancreatic endocrine tumorCarcinoid TumorCabozantinib S-malate
Sources: Dmand AI Research Linkage; and ClinicalTrials.gov (National Library of Medicine)
Dr. Liudmila N. Schafer received $627 in industry payments from 2016 to 2025
CMS Open Payments shows 14 general payments to Dr. Schafer from 8 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 100% of the total. GlaxoSmithKline, LLC. paid the most, $150.
General payments to Dr. Schafer by program year, 2016 to 2025
Companies that paid Dr. Schafer the most, 2016 to 2025
Share is of all general payments to this clinician.
Source: Open Payments (CMS), 2025 data, released July 7, 2026
Sources for Dr. Liudmila N. Schafer's profile data
| Data on this page | Source |
|---|---|
| NPI, name, sex, specialty and licenses | NPPES NPI Registry (CMS) (opens in a new tab)Dmand AI Professional Profile Data |
| Practice locations and phone | Dmand AI Affiliation Data |
| Primary practice, affiliations and health system | Dmand AI Affiliation DataDmand AI Org Hierarchy Data |
| Medicare services and procedure codes | Medicare Physician & Other Practitioners - by Provider and Service (CMS) (opens in a new tab) |
| State medians for the same specialty | Dmand AI Peer Benchmarks |
| Medicare patients and the all-payer patient panel | Dmand AI Patient Panel Data |
| Part D prescribing | Medicare Part D Prescribers - by Provider and Drug (CMS) (opens in a new tab)Medicare Part D Prescribers - by Provider (CMS) (opens in a new tab) |
| MIPS scores, telehealth, assignment and procedure percentiles | Doctors and Clinicians National Downloadable File (CMS) (opens in a new tab) |
| Publications, topics and co-authors | PubMed (National Library of Medicine) (opens in a new tab)Dmand AI Research Linkage |
| Clinical trials and co-investigators | Dmand AI Research LinkageClinicalTrials.gov (National Library of Medicine) (opens in a new tab) |
| Industry payments | Open Payments (CMS) (opens in a new tab) |
| EHR at each practice site | Dmand AI Technology Install Data |
| Similar physicians | Dmand AI Affiliation Data |
Data last refreshed October 2026Report an inaccuracyRemove my information
FAQ
Frequently asked questions about Dr. Liudmila N. Schafer
Spotted something out of date? Email hello@dmand.ai and we will check the record. Contact details live in the free trial.
What is Dr. Liudmila N. Schafer's NPI number?
Dr. Liudmila N. Schafer's NPI number is 1114106515. It was assigned on November 1, 2007, and it is active in the NPI Registry.
What kind of doctor is Dr. Liudmila N. Schafer?
Dr. Liudmila N. Schafer is a hematologist and oncologist in Washington, District of Columbia. The primary specialty in the NPI Registry is Hematology & Oncology Physician (taxonomy code 207RH0003X).
Where does Dr. Liudmila N. Schafer practice?
Dr. Schafer practices at 110 Irving Street NW, Washington, DC 20010. Dr. Schafer's primary practice is MedStar Washington Hospital Center in Washington, District of Columbia, part of MedStar Health. Dmand AI also links Dr. Schafer to 3 hospitals, 4 medical groups and 3 group practices and clinics.
What is Dr. Liudmila N. Schafer's office phone number?
The practice phone on file for Dr. Schafer is (202) 877-7000.
What is Dr. Liudmila N. Schafer's medical license number?
Dr. Schafer holds Missouri license 2019047145, one of the licenses on file in 4 states.
Which states has Dr. Liudmila N. Schafer been licensed in?
Dmand AI has state licenses on file for Dr. Schafer in Missouri, Arkansas, Kansas and Tennessee.
Which hospitals is Dr. Liudmila N. Schafer affiliated with?
Dr. Schafer practices at MedStar Washington Hospital Center in Washington, District of Columbia. Dr. Schafer is also affiliated with MedStar Georgetown University Hospital. Dmand AI links Dr. Schafer to 3 more hospitals.
What medical group is Dr. Liudmila N. Schafer part of?
Dr. Schafer is linked to MedStar Medical Group. Dmand AI links Dr. Schafer to 4 more medical groups.
Does Dr. Liudmila N. Schafer accept Medicare?
Yes. CMS data shows Dr. Schafer billed Medicare for 245 services in 2023, and Dr. Schafer accepts Medicare assignment.
Does Dr. Liudmila N. Schafer offer telehealth?
Yes. The CMS Doctors and Clinicians file lists Dr. Schafer as offering telehealth services.
Show 6 more questionsShow fewer questions
What services does Dr. Liudmila N. Schafer bill to Medicare?
In 2023, Dr. Schafer's most billed Medicare services were office visit, established patient (99214), office visit, established patient (99213) and office visit, established patient (99215).
What drugs does Dr. Liudmila N. Schafer prescribe most?
In 2024 Medicare Part D data, Dr. Schafer's most prescribed drugs by claims were Eliquis.
Has Dr. Liudmila N. Schafer received payments from drug or device companies?
CMS Open Payments shows $627 in general payments to Dr. Schafer from 8 companies from 2016 to 2025. The largest total came from GlaxoSmithKline, LLC.
How long has Dr. Liudmila N. Schafer been practicing?
Dr. Schafer graduated from medical school in 1996, 30 years ago.
Does Dr. Liudmila N. Schafer do research?
Dmand AI links 3 publications to Dr. Schafer. Dr. Schafer has worked on 6 clinical trials.
Who does Dr. Liudmila N. Schafer publish with?
Dr. Schafer's most frequent co-authors are Matthew C. Aboudara, MD (1 shared paper), Konstantinos Arnaoutakis, MD (1 shared paper) and John J. Borsa, MD (1 shared paper).
Selling to hematology and oncology practices?
See hematologists and oncologists in District of Columbia by site of care and group
Find the practices, groups and hospitals they work with, and the right people to contact at each.
- 30 days free
- Self-serve
- No credit card